Acute Myeloid Leukemia Market Size and Share to Rise by 2032, Predicts DelveInsight | Key Companies - Chimerix, GlycoMimetics, Arog, Delta-Fly, Jasper, Jazz, Daiichi Sankyo, Amgen, AbbVie, Merck, Eli Lilly
August 07, 2023 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Aug. 07, 2023 (GLOBE NEWSWIRE) -- Acute Myeloid Leukemia Market Size and Share to Rise by 2032, Predicts DelveInsight | Key Companies - Chimerix, GlycoMimetics, Arog, Delta-Fly,...
Relapsed/Refractory Acute Myeloid Leukemia Pipeline Analysis: 60+ Leading Companies are Working to Improve the Treatment Landscape
September 06, 2022 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Sept. 06, 2022 (GLOBE NEWSWIRE) -- Relapsed/Refractory Acute Myeloid Leukemia Pipeline Analysis: 60+ Leading Companies are Working to Improve the Treatment Landscape DelveInsight’s...
AbbVie/Roche’s Venclexta is Set to Remain the Acute Myeloid Leukemia Drugs Market Leader | GlobalData Plc
July 14, 2022 08:15 ET
|
GlobalData Plc
LONDON, July 14, 2022 (GLOBE NEWSWIRE) -- The “Acute Myeloid Leukemia (AML) – Opportunity Analysis and Forecasts to 2029” report offered by GlobalData provides an overview of AML including...
Acute Myeloid Leukemia Pipeline Assessment 2021 report covers Unmet Needs, Key Opportunities, and Major Players
February 15, 2021 20:00 ET
|
DelveInsight Business Research LLP
Los Angeles, USA, Feb. 15, 2021 (GLOBE NEWSWIRE) -- Acute Myeloid Leukemia Pipeline Assessment 2021 report covers Unmet Needs, Key Opportunities, and Major Players DelveInsight highlights recent...